[1]
|
Khan, N., Afaq, F. and Mukhtar, H. (2010) Lifestyle as Risk Factor for Cancer: Evidence from Human Studies. Cancer Letters, 293, 133-143. https://doi.org/10.1016/j.canlet.2009.12.013
|
[2]
|
Ling, L.-H., Kistler, P.M., Kalman, J.M., Schilling, R.J. and Hunter, R.J. (2016) Comorbidity of Atrial Fibrillation and Heart Failure. Nature Reviews Cardiology, 13, 131-147. https://doi.org/10.1038/nrcardio.2015.191
|
[3]
|
Wutzler, A., Krogias, C., Grau, A., Veltkamp, R., Heuschmann, P.U. and Haeusler, K.G. (2019) Stroke Prevention in Patients with Acute Ischemic Stroke and Atrial Fibrillation in Germany—A Cross Sectional Survey. BMC Neurology, 19, 1-4. https://doi.org/10.1186/s12883-019-1249-y
|
[4]
|
Anumonwo, J.M.B. and Kalifa, J. (2016) Risk Factors and Genetics of Atrial Fibrillation. Cardiology Clinics, 12, 157-166. https://doi.org/10.1016/j.hfc.2015.08.013
|
[5]
|
Tu, N.N., Hilmer, S.N. and Cumming, R.G. (2013) Review of Epidemiology and Management of Atrial Fibrillation in Developing Countries. International Journal of Cardiology, 167, 2412-2420. https://doi.org/10.1016/j.ijcard.2013.01.184
|
[6]
|
Fumagalli, S., Barchielli, A., Tarantini, F., Gabbai, D., Rinaldi, M.C., Fracchia, S., et al. (2012) Atrial Fibrillation and Cancer: Evidence for an Epidemiological Link. Journal of the American College of Cardiology, 59, E615. https://doi.org/10.1016/S0735-1097(12)60616-0
|
[7]
|
Hung, C.S., Chang, C.H., Lin, J.W., Ho, Y.L. and Chen, M.F. (2018) The Association between New Onset Atrial Fibrillation and Incident Cancer—A Nationwide Cohort Study. PLoS ONE, 13, e0199901. https://doi.org/10.1371/journal.pone.0199901
|
[8]
|
Jacob, K.A., Nathoe, H.M., Dieleman, J.M., van Osch, D., Kluin, J. and van Dijk, D. (2014) Inflammation in New-Onset Atrial Fibrillation after Cardiac Surgery: A Systematic Review. European Journal of Clinical Investigation, 44, 402-428. https://doi.org/10.1111/eci.12237
|
[9]
|
Rahman, F., Ko, D. and Benjamin, E.J. (2016) Association of Atrial Fibrillation and Cancer. JAMA Cardiology, 1, 384-386. https://doi.org/10.1001/jamacardio.2016.0582
|
[10]
|
Fitzpatrick, T., Carrier, M. and Gal, G.L. (2017) Cancer, Atrial Fibrillation, and Stroke. Thrombosis Research, 155, 101-105. https://doi.org/10.1016/j.thromres.2017.05.006
|
[11]
|
O’Neal, W.T., Lakoski, S.G., et al. (2015) Relation between Cancer and Atrial Fibrillation (From the Reasons for Geographic and Racial Differences in Stroke Study). The American Journal of Cardiology, 115, 1090-1094. https://doi.org/10.1016/j.amjcard.2015.01.540
|
[12]
|
Dimitrios, F., John, P. and Gerasimos, F. (2014) Insights into Onco-Cardiology: Atrial Fibrillation in Cancer. Journal of the American College of Cardiology, 63, 945-953. https://doi.org/10.1016/j.jacc.2013.11.026
|
[13]
|
Cheng, W.L., Kao, Y.H., Chen, S.A. and Chen, Y.J. (2016) Pathophysiology of Cancer Therapy-Provoked Atrial Fibrillation. International Journal of Cardiology, 219, 186-194. https://doi.org/10.1016/j.ijcard.2016.06.009
|
[14]
|
Lee, Y.Y. and Derakhshan, M.H. (2013) Environmental and Lifestyle Risk Factors of Gastric Cancer. Archives of Iranian Medicine, 16, 358-365.
|
[15]
|
Andrea, F., Damian, S., Sune, F., Michael, K., Milan, S., Alexander, R., et al. (2013) STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration. Nucleic Acids Research, 41, D808-D815. https://doi.org/10.1093/nar/gks1094
|
[16]
|
Poos, K., Smida, J., Nathrath, M., Maugg, D., Baumhoer, D. and Korsching, E. (2012) How MicroRNA and Transcription Factor Co-Regulatory Networks Affect Osteosarcoma Cell Proliferation. PLoS Computational Biology, 9, 262-279. https://doi.org/10.1371/journal.pcbi.1003210
|
[17]
|
Feng, Y., Wang, Q. and Wang, T. (2017) Drug Target Protein-Protein Interaction Networks: A Systematic Perspective. Biomed Research International, 2017, Article ID: 1289259. https://doi.org/10.1155/2017/1289259
|
[18]
|
Chea, E. and Livesay, D.R. (2007) How Accurate and Statistically Robust Are Catalytic Site Predictions Based on Closeness Centrality? BMC Bioinformatics, 8, 153-166. https://doi.org/10.1186/1471-2105-8-153
|
[19]
|
Jansen, M., Treutner, K.H., Schmitz, B., Otto, J. and Schumpelick, V. (2004) Phospholipids Reduce Gastric Cancer Cell Adhesion to Extracellular Matrix in Vitro. BMC Gastroenterology, 4, 33-37. https://doi.org/10.1186/1471-230X-4-33
|
[20]
|
Tu, S., Jiang, X., Lin, M., Cui, J., Yang, Y., Lum, C., et al. (2003) Suppression of Survivin Expression Inhibits in Vivo Tumorigenicity and Angiogenesis in Gastric Cancer. Cancer Research, 63, 7724-7732.
|
[21]
|
Takeda, H. (1990) Immunohistochemical Studies of Basement Membrane Components in Primary and Metastatic Lesions of Early Gastric Cancer. Journal of Nippon Medical School, 57, 160-171. https://doi.org/10.1272/jnms1923.57.160
|
[22]
|
Chung, H., Kong, H. and Lim, J.-B. (2015) Clinical Significance and Usefulness of Soluble Heparin Binding-Epidermal Growth Factor in Gastric Cancer. World Journal of Gastroenterology, 21, 2080-2088. https://doi.org/10.3748/wjg.v21.i7.2080
|
[23]
|
Jogestrand, T. (1980) Digoxin Concentration in Right Atrial Myocardium, Skeletal Muscle and Serum in Man: Influence of Atrial Rhythm. European Journal of Clinical Pharmacology, 17, 243-250. https://doi.org/10.1007/BF00625797
|
[24]
|
Roussos, E.T., Condeelis, J.S. and Antonia, P. (2011) Chemotaxis in Cancer. Nature Reviews Cancer, 11, 573-587. https://doi.org/10.1038/nrc3078
|
[25]
|
Duan, K.D., Li, Y.-S. and Shi, X.J. (2011) Effects of Serum from Patients with Atrial Fibrillation on Chemotaxis of Cardiac Fibroblasts. Chinese Journal of Pathophysiology, 27, 662-665.
|
[26]
|
Lee, K., Hwang, H. and Nam, K.T. (2014) Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer. Gut & Liver, 8, 131-139. https://doi.org/10.5009/gnl.2014.8.2.131
|
[27]
|
Liu, L., Zheng, Q., Lee, J., Ma, Z., Zhu, Q. and Wang, Z. (2015) PD-1/PD-L1 Expression on CD4+ T Cells and Myeloid DCs Correlates with the Immune Pathogenesis of Atrial Fibrillation. Journal of Cellular & Molecular Medicine, 19, 1223-1233. https://doi.org/10.1111/jcmm.12467
|
[28]
|
Sung, B.H. and Weaver, A.M. (2017) Exosome Secretion Promotes Chemotaxis of Cancer Cells. Cell Adhesion & Migration, 11, 187-195. https://doi.org/10.1080/19336918.2016.1273307
|
[29]
|
Hua, Y., Drew, P. and Richard, J. (2009) STATs in Cancer Inflammation and Immunity: A Leading Role for STAT3. Nature Reviews Cancer, 11, 798-809. https://doi.org/10.1038/nrc2734
|
[30]
|
Kanda, N., Seno, H., Konda, Y., Marusawa, H. and Chiba, T. (2004) STAT3 Is Constitutively Activated and Supports Cell Survival in Association with Survivin Expression in Gastric Cancer Cells. Oncogene, 23, 4921-4929. https://doi.org/10.1038/sj.onc.1207606
|
[31]
|
Deng, J., Liang, H., Zhang, R., Sun, D., Pan, Y., Liu, Y., et al. (2013) STAT3 Is Associated with Lymph Node Metastasis in Gastric Cancer. Tumor Biology, 34, 2791-2800. https://doi.org/10.1007/s13277-013-0837-5
|
[32]
|
Zhang, Q., Xu, F., Shi, Y., Chen, Y.W., Wang, H.P., Yu, X., et al. (2017) C-X-C Motif Chemokine Receptor 4 Promotes Tumor Angiogenesis in Gastric Cancer via Activation of JAK2/STAT3. Cell Biology International, 41, 854-862. https://doi.org/10.1002/cbin.10794
|
[33]
|
Yang, L., Zhang, S., Guo, K., Huang, H., Qi, S., Yao, J., et al. (2018) miR-125a Restrains Cell Migration and Invasion by Targeting STAT3 in Gastric Cancer Cells. OncoTargets and Therapy, 12, 205-215. https://doi.org/10.2147/OTT.S168454
|
[34]
|
Kim, D.Y., Cha, S.T., Ahn, D.H., Kang, H.Y., Kwon, C.I., Ko, K.H., et al. (2009) STAT3 Expression in Gastric Cancer Indicates a Poor Prognosis. Journal of Gastroenterology & Hepatology, 24, 646-651. https://doi.org/10.1111/j.1440-1746.2008.05671.x
|
[35]
|
孙阳, 赵春临. 纤维连接蛋白1在胃癌中的表达及临床意义[J]. 医学研究生学报, 2019, 32(6): 629-633.
|
[36]
|
Zhang, H., Sun, Z., Li, Y., Fan, D. and Jiang, H. (2017) MicroRNA-200c Binding to FN1 Suppresses the Proliferation, Migration and Invasion of Gastric Cancer Cells. Biomedicine & Pharmacotherapy, 88, 285-292. https://doi.org/10.1016/j.biopha.2017.01.023
|
[37]
|
Chen, H.B. and Zheng, H.T. (2017) MicroRNA-200c Represses Migration and Invasion of Gastric Cancer SGC-7901 Cells by Inhibiting Expression of Fibronectin 1. European Review for Medical and Pharmacological Sciences, 21, 1753-1758.
|
[38]
|
Kim, M.S., Lee, S.H., Yoo, N.J. and Lee, S.H. (2013) Frameshift Mutations of Tumor Suppressor Gene EP300 in Gastric and Colorectal Cancers with High Microsatellite Instability. Human Pathology, 44, 2064-2070. https://doi.org/10.1016/j.humpath.2012.11.027
|
[39]
|
Tao, Y., Chen, Y.C., Li, Y.Y., Yang, S.Q. and Xu, W.R. (2008) Localization and Translocation of RhoA Protein in the Human Gastric Cancer Cell Line SGC-7901. World Journal of Gastroenterology, 14, 1175-1181. https://doi.org/10.3748/wjg.14.1175
|
[40]
|
Yoon, J.H., Choi, W.S., Kim, O., Choi, B.J. and Park, W.S. (2016) Gastrokine 1 Inhibits Gastric Cancer Cell Migration and Invasion by Downregulating RhoA Expression. Gastric Cancer, 20, 1-12. https://doi.org/10.1007/s10120-016-0617-1
|
[41]
|
Hu, L., Wu, H., Wan, X., Liu, L., He, Y., Zhu, L., et al. (2018) MicroRNA-585 Suppresses Tumor Proliferation and Migration in Gastric Cancer by Directly Targeting MAPK1. Biochemical and Biophysical Research Communications, 499, 52-58. https://doi.org/10.1016/j.bbrc.2018.03.116
|
[42]
|
Bojian, F. and Haorong, W. (2012) MiR-378 Inhibits Progression of Human Gastric Cancer MGC-803 Cells by Targeting MAPK1 in Vitro. Oncology Research, 20, 557-564. https://doi.org/10.3727/096504013X13775486749254
|
[43]
|
卢燕华, 唐三元. miR-217靶向MAPK1抑制胃癌细胞侵袭转移作用研究[J]. 中国现代医药杂志, 2014, 16(11): 21-23.
|
[44]
|
Pan, D.Y., Zeng, X.Q., Ma, G.F., Gao, J., Li, N., Miao, Q., et al. (2018) Label-Free Quantitative Proteomic Analysis Identifies CTNNB1 as a Direct Target of FOXP3 in Gastric Cancer Cells. Oncology Letters, 15, 7655-7660. https://doi.org/10.3892/ol.2018.8277
|
[45]
|
He, B., Xiao, Y.-F., Tang, B., Wu, Y.-Y., Hu, C.-J., Xie, R., et al. (2016) hTERT Mediates Gastric Cancer Metastasis Partially through the Indirect Targeting of ITGB1 by microRNA-29a. Scientific Reports, 6, 1-12. https://doi.org/10.1038/srep21955
|
[46]
|
Hu, C., Ni, Z., Li, B.S., Yong, X. and Yang, S.-M. (2015) hTERT Promotes the Invasion of Gastric Cancer Cells by Enhancing FOXO3a Ubiquitination and Subsequent ITGB1 Upregulation. Gut, 66, 31-42. https://doi.org/10.1136/gutjnl-2015-309322
|
[47]
|
Du, D., Yang, X., Wang, Q., Dai, W., Kuai, W., Liu, Y.L., et al. (2016) Effects of CDC42 on the Proliferation and Invasion of Gastric Cancer Cells. Molecular Medicine Reports, 13, 550-554. https://doi.org/10.3892/mmr.2015.4523
|
[48]
|
Cheng, Z., Liu, F., Wang, G., Li, Y., Zhang, H. and Li, F. (2014) miR-133 Is a Key Negative Regulator of CDC42-PAK Pathway in Gastric Cancer. Cellular Signalling, 26, 2667-2673. https://doi.org/10.1016/j.cellsig.2014.08.012
|
[49]
|
Li, X., Jiang, M., Chen, D., Xu, B., Wang, R., Chu, Y., et al. (2018) miR-148b-3p Inhibits Gastric Cancer Metastasis by Inhibiting the Dock6/Rac1/Cdc42 Axis. Journal of Experimental & Clinical Cancer Research, 37, 71-85. https://doi.org/10.1186/s13046-018-0729-z
|
[50]
|
Tahara, T., Shibata, T., Okamoto, Y., Yamazaki, J. and Ohmiya, N. (2016) Mutation Spectrum of TP53 Gene Predicts Clinicopathological Features and Survival of Gastric Cancer. Oncotarget, 7, 42252-42260. https://doi.org/10.18632/oncotarget.9770
|
[51]
|
Abdalla, L.F., Santos, J.H.A., Barreto, R.T.J., Souza, E.M., D’Assuncao, F.F., Borges, M.A., et al. (2018) Atrial Fibrillation in a Patient with Zika Virus Infection. Virology Journal, 15, 23-28. https://doi.org/10.1186/s12985-018-0938-2
|
[52]
|
Xu, J.B., Zhang, C.H., He, Y.L., Hui, W., Zhao, W., Wu, S., et al. (2015) Lymphatic Endothelial Cell-Secreted CXCL1 Stimulates Lymphangiogenesis and Metastasis of Gastric Cancer. International Journal of Cancer, 130, 787-797. https://doi.org/10.1002/ijc.26035
|
[53]
|
Wang, Z., Wang, Z., Li, G., Wu, H., Sun, K., Chen, J., et al. (2017) CXCL1 from Tumor-Associated Lymphatic Endothelial Cells Drives Gastric Cancer Cell into Lymphatic System via Activating Integrin β1/FAK/AKT Signaling. Cancer Letters, 385, 28-38. https://doi.org/10.1016/j.canlet.2016.10.043
|
[54]
|
Wei, Z.W., Xia, G.K., Wu, Y., Chen, W., Xiang, Z., Schwarz, R.E., et al. (2015) CXCL1 Promotes Tumor Growth through VEGF Pathway Activation and Is Associated with Inferior Survival in Gastric Cancer. Cancer Letters, 359, 335-343. https://doi.org/10.1016/j.canlet.2015.01.033
|
[55]
|
Wang, Z., Liu, H., Shen, Z., Wang, X., Zhang, H., Qin, J., et al. (2015) The Prognostic Value of CXC-Chemokine Receptor 2 (CXCR2) in Gastric Cancer Patients. BMC Cancer, 15, 766-773. https://doi.org/10.1186/s12885-015-1793-9
|
[56]
|
Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., et al. (2016) Repertaxin, an Inhibitor of the Chemokine Receptors CXCR1 and CXCR2, Inhibits Malignant Behavior of Human Gastric Cancer MKN45 Cells in Vitro and in Vivo and Enhances Efficacy of 5-Fluorouracil. International Journal of Oncology, 48, 1341-1352. https://doi.org/10.3892/ijo.2016.3371
|
[57]
|
Li, Z., Wang, Y., Dong, S., Ge, C., Xiao, Y., Li, R., et al. (2014) Association of CXCR1 and 2 Expressions with Gastric Cancer Metastasis in Ex Vivo and Tumor Cell Invasion in Vitro. Cytokine, 69, 6-13. https://doi.org/10.1016/j.cyto.2014.05.004
|
[58]
|
Xiang, Z., Zhou, Z.J., Xia, G.K., Zhang, X.H., Wei, Z.W., Zhu, J.T., et al. (2017) A Positive Crosstalk between CXCR4 and CXCR2 Promotes Gastric Cancer Metastasis. Oncogene, 36, 1-12. https://doi.org/10.1038/onc.2017.108
|
[59]
|
Wang, X.X., Zhang, F.R., Zhu, J.H., Xie, X.D. and Chen, J.Z. (2009) Up-Regulation of CXC Chemokine Receptor 4 Expression in Chronic Atrial Fibrillation Patients with Mitral Valve Disease May Be Attenuated by Renin-Angiotensin System Blockers. Journal of International Medical Research, 37, 1145-1151. https://doi.org/10.1177/147323000903700419
|